Dallas Formulations Private Limited, a active private limited company, was established on 24 November 2000 in Ujjain, Madhya Pradesh, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24233MP2000PTC014476. Registered under ROC Roc Gwalior. it is unlisted. It has an authorized capital of ₹5.00 M and a paid-up capital of ₹3.91 M.
Formerly known as Chirayu Ayurveda Private Limited. It upholds a compliant status. Employing 22 professional, Its leadership includes Rajesh Gupta (Director), Mukesh Kumar (Whole-Time Director). Past directors included Jambukumar Jain, Nandkishore Maheshwari, Anil Kumar. It holds ₹2.66 Cr open charges and ₹5.24 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 220,Block-C, 2Nd Floor Madhav Club Road, Dawa Bazar, Ujjain, Madhya Pradesh, 456010.
U24233MP2000PTC014476
014476
24 November 2000
₹5.00 M
₹3.91 M
Roc Gwalior
Unlisted
Active
Explore comprehensive insights into Dallas Formulations Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajesh Gupta | Director | 16 Jan 2006 | Current |
| Mukesh Kumar | Whole-Time Director | 21 Jul 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 25 Jul 2015 | Past |
| Pramod Abcsdd | Director | 04 Oct 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2019 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Dallas Formulations Private Limited, for the financial year ended 2024, experienced Minor drop in revenue, with a 6.75% decrease. The company also saw a substantial improvement in profitability, with a 501.87% increase in profit. The company's net worth moved up by a moderate rise of 4.2%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Dallas Formulations had a public holding of 40.79%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹26,600,000.00
₹52,406,912.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2006 | State Bank Of India | ₹2.66 Cr | Open |
| 28 Nov 2013 | Ing Vysya Bank Limited | ₹1.75 Cr | Satisfied |
| 17 Aug 2011 | Dir. Of Industries With Parri Passu Sbi Baddi | ₹1.29 Cr | Satisfied |
| 29 Apr 2006 | State Bank Of India | ₹2.20 Cr | Satisfied |
Explore comprehensive loan charge details -
Dallas Formulations has a workforce of 22 employees as of Mar 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Dallas Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dallas Formulations's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge registered on 17 Aug 2011 via Charge ID 10302287 with Dir. Of Industries With Parri Passu Sbi Baddi was fully satisfied on 22 Apr 2025. was completed.
Progress on Dallas Formulations Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Dallas Formulations Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Gwalior. was recorded as a recent event.
Progress on A charge with State Bank Of India of Rs. 26.60 M registered on 11 Nov 2006 with Charge ID 10030257 was modified on 15 May 2023. was documented.
Progress on Mukesh Kumar was appointed as a Whole-time director was appointed as a Whole-time director on 21 Jul 2022 & has been associated with this company since 3 years 5 months . was documented.
The activity A charge registered on 28 Nov 2013 via Charge ID 10466437 with Ing Vysya Bank Limited was fully satisfied on 29 Oct 2014. was completed.
The CIN of Dallas Formulations Private Limited is U24233MP2000PTC014476.
Dallas Formulations Private Limited is headquartered at 220,Block-C, 2Nd Floor Madhav Club Road, Dawa Bazar, Ujjain, Madhya Pradesh, 456010.
Dallas Formulations Private Limited was incorporated on 24 November 2000.
The current directors of Dallas Formulations Private Limited are
The primary industry of Dallas Formulations Private Limited is Manufacturing.
Dallas Formulations Private Limited is unlisted.
The authorized capital of Dallas Formulations Private Limited is ₹5.00 M, and the paid-up capital is ₹3.91 M.
The compliance status of Dallas Formulations Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX